Natixis Advisors’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,761
| Closed | -$504K | – | 1665 |
|
|
2025
Q1 | $504K | Buy |
17,761
+7,356
| +71% | +$209K | ﹤0.01% | 1454 |
|
|
2024
Q4 | $433K | Sell |
10,405
-1,169
| -10% | -$48.6K | ﹤0.01% | 1501 |
|
|
2024
Q3 | $773K | Sell |
11,574
-58,936
| -84% | -$3.94M | ﹤0.01% | 1364 |
|
|
2024
Q2 | $8.37M | Buy |
70,510
+40,021
| +131% | +$4.75M | 0.02% | 658 |
|
|
2024
Q1 | $3.25M | Buy |
30,489
+5,877
| +24% | +$626K | 0.01% | 901 |
|
|
2023
Q4 | $2.45M | Buy |
24,612
+4,688
| +24% | +$466K | 0.01% | 944 |
|
|
2023
Q3 | $2.06M | Buy |
19,924
+3,310
| +20% | +$342K | 0.01% | 980 |
|
|
2023
Q2 | $2.02M | Sell |
16,614
-12,709
| -43% | -$1.54M | 0.01% | 958 |
|
|
2023
Q1 | $4.5M | Buy |
29,323
+573
| +2% | +$88K | 0.02% | 717 |
|
|
2022
Q4 | $5.16M | Buy |
28,750
+3,313
| +13% | +$595K | 0.02% | 675 |
|
|
2022
Q3 | $3.01M | Buy |
25,437
+13,586
| +115% | +$1.61M | 0.01% | 768 |
|
|
2022
Q2 | $1.69M | Sell |
11,851
-1,586
| -12% | -$227K | 0.01% | 960 |
|
|
2022
Q1 | $2.32M | Buy |
13,437
+3,178
| +31% | +$548K | 0.01% | 920 |
|
|
2021
Q4 | $2.61M | Sell |
10,259
-67,297
| -87% | -$17.1M | 0.01% | 876 |
|
|
2021
Q3 | $29.8M | Sell |
77,556
-145,991
| -65% | -$56.2M | 0.12% | 175 |
|
|
2021
Q2 | $52.5M | Buy |
+223,547
| New | +$52.5M | 0.25% | 95 |
|